MX9100367A - Derivados de heteroarilcetona y procedimiento para su preparacion - Google Patents

Derivados de heteroarilcetona y procedimiento para su preparacion

Info

Publication number
MX9100367A
MX9100367A MX9100367A MX9100367A MX9100367A MX 9100367 A MX9100367 A MX 9100367A MX 9100367 A MX9100367 A MX 9100367A MX 9100367 A MX9100367 A MX 9100367A MX 9100367 A MX9100367 A MX 9100367A
Authority
MX
Mexico
Prior art keywords
heteroarilcetone
derivatives
procedure
preparation
Prior art date
Application number
MX9100367A
Other languages
English (en)
Inventor
Peter Charles Thomas Hannan
Peter John O'hanlon
Neil David Pearson
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016895A external-priority patent/GB9016895D0/en
Priority claimed from GB919105584A external-priority patent/GB9105584D0/en
Priority claimed from GB919107897A external-priority patent/GB9107897D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of MX9100367A publication Critical patent/MX9100367A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX9100367A 1990-08-01 1991-07-25 Derivados de heteroarilcetona y procedimiento para su preparacion MX9100367A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909016895A GB9016895D0 (en) 1990-08-01 1990-08-01 Novel compounds
GB919105584A GB9105584D0 (en) 1991-03-16 1991-03-16 Novel compounds
GB919107897A GB9107897D0 (en) 1991-04-13 1991-04-13 Novel compounds

Publications (1)

Publication Number Publication Date
MX9100367A true MX9100367A (es) 1992-04-01

Family

ID=27265210

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100367A MX9100367A (es) 1990-08-01 1991-07-25 Derivados de heteroarilcetona y procedimiento para su preparacion

Country Status (10)

Country Link
EP (1) EP0544705A1 (es)
JP (1) JPH06502395A (es)
KR (1) KR930701431A (es)
AU (1) AU651988B2 (es)
CA (1) CA2088505A1 (es)
IE (1) IE912684A1 (es)
MX (1) MX9100367A (es)
NZ (1) NZ239191A (es)
PT (1) PT98511A (es)
WO (1) WO1992002518A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201391D0 (en) * 1992-01-22 1992-03-11 Smithkline Beecham Plc Method of treatment
JPH07503244A (ja) * 1992-01-24 1995-04-06 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 抗菌性1−ノルモン−2−イルチアゾリルケトン類
JPH0665203A (ja) * 1992-06-25 1994-03-08 Elf Sanofi ピペラジンのヘテロ環誘導体
EP0580465A1 (fr) * 1992-06-25 1994-01-26 Sanofi Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés
GB9215854D0 (en) * 1992-07-25 1992-09-09 Smithkline Beecham Plc Novel compounds
GB9320561D0 (en) * 1993-10-06 1993-11-24 Zeneca Ltd Heterocyclic compounds
WO1997005126A1 (en) * 1995-07-29 1997-02-13 Smithkline Beecham Plc Mupirocinsulfamates with antibacterial activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
EP0029665B1 (en) * 1979-11-10 1984-02-01 Beecham Group Plc Antibacterial derivatives of monic acid, processes for their preparation and compositions containing them
GB8928839D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
WO1992002518A1 (en) 1992-02-20
AU651988B2 (en) 1994-08-11
AU8310491A (en) 1992-03-02
IE912684A1 (en) 1992-02-12
CA2088505A1 (en) 1992-02-02
EP0544705A1 (en) 1993-06-09
KR930701431A (ko) 1993-06-11
NZ239191A (en) 1994-04-27
PT98511A (pt) 1992-06-30
JPH06502395A (ja) 1994-03-17

Similar Documents

Publication Publication Date Title
MX9101793A (es) Derivados de tiazolidindiona y procedimiento para su preparacion
MX9100529A (es) Derivados substituidos de oxazolidindiona y proceso para su preparacion
MX9100720A (es) Derivados de valinamida y procedimiento para su obtencion
MX9202290A (es) Nuevos derivados de tiopiranopirrol y procedimiento para su preparacion.
MX23672A (es) Derivados de glicopeptidos y procedimiento para su preparacion.
MX9201103A (es) Derivados de 3-hidroxi-4-aril-5-oxo-pirazolina y procedimiento par su obtencion
MX9200105A (es) Derivados de cefem y procedimientos para su preparacion
MX9205279A (es) Derivados de benzanilida y procedimiento para su preparacion
MX9205278A (es) Derivados de benzanilida y procedimiento para su preparacion
MX9101237A (es) Xantinas substituidas y procedimiento para su preparacion
MX9202281A (es) Derivados de benzofurano y procedimiento para su preparacion.
MX9202022A (es) Derivados de pirazina y proceso para su preparacion.
MX21917A (es) Derivados de benzopirano y benzotiopirano y procedimiento para su preparacion.
MX9207620A (es) Derivados de bencenmetanamina a-substituidos y procedimiento para su preparacion.
MX9101516A (es) Derivados de 1,2,5,6-tetrahidropiridin 3-cetoxima y-3-aldoxina y procedimiento para su preparacion
MX9101235A (es) Xantinas substituidas y procedimiento para su preparacion
MX9100811A (es) Indolonaftiridinas y procedimiento para su preparacion
MX9100845A (es) Nuevas tienodiazepinas y procedimiento para su preparacion
MX9203836A (es) Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion.
MX9100415A (es) Piridinas substituidas y procedimiento para su obtencion
MX9100742A (es) Composicion farmaceutica y procedimiento para su preparacion
MX9100367A (es) Derivados de heteroarilcetona y procedimiento para su preparacion
MX9100388A (es) Derivados de carboximetilciclopropano y procedimiento para su preparacion
MX174227B (es) Composicion de mezclas anhidras de paraclorometaxilenol y metodo para su preparacion
MX9207619A (es) Derivados de bencenmetanamina heterocilcicamente substituida y procedimiento para su preparacion.